Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Residual Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableLooking for participantsNCT05802394
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced
Peking Union Medical College Hospital 100
Not applicableUnknownNCT03189576
What this trial is testing

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

Who this might be right for
Colorectal CancerResidual Disease
Tampere University Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT07071961
What this trial is testing

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Who this might be right for
Colorectal CancerRegorafenibHigh Risk Patients
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT04274283
What this trial is testing

Tessa Jowell BRAIN MATRIX - Platform Study

Who this might be right for
Glioma
University of Birmingham 1,000
Not applicableLooking for participantsNCT07775950
What this trial is testing

Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRD

Who this might be right for
Colorectal Cancer (MSI-H)Molecular Residual Disease
Sun Yat-sen University 100
Not applicableLooking for participantsNCT02306096
What this trial is testing

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Who this might be right for
Breast Neoplasms
Lund University 20,000
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292207
What this trial is testing

Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer

Who this might be right for
ctDNA MonitoringBreast Cancer
Nagoya City University 30
Not applicableActive Not RecruitingNCT06566729
What this trial is testing

MRD in High-risk EBC

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 125